Tottenham have completed the Premier League double over Manchester City nine times so far, more than they have any other opponent. Meanwhile, only Chelsea (10) have done so more a ...
Amgen is facing a slowdown in uptake of its first-to-market KRAS inhibitor Lumakras as a second-line therapy for KRAS-mutated non-small cell lung cancer (NSCLC), so is understandably excited by new ...
Centralized migration accelerates adaptation and drives parallel evolution, emphasizing the key influence of spatial organization on evolutionary dynamics across systems from pathogen transmission to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results